Upsher-Smith Laboratories, Inc.

192 articles with Upsher-Smith Laboratories, Inc.

• Upsher-Smith Launches Isotretinoin Capsules

  6/25/2021

   Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Isotretinoin Capsules.

• Upsher-Smith And The National Alliance Of State Pharmacy Associations (NASPA) Honor 42 U.S. Pharmacists For Their Excellence In Innovation

  2/8/2021

  Upsher-Smith Laboratories, LLC and the National Alliance of State Pharmacy Associations are pleased to honor the 2020 NASPA Excellence in Innovation Award recipients.

• Migraine Patients With High-Deductible Commercial Healthcare Plans To Benefit From Upsher-Smith's Expanded Access Pathways Program

  2/1/2021

  Now Offers Commercially Insured Patients $0 Copay and Free Home Delivery for Acute and Preventive Migraine Treatment Options

• Upsher-Smith Launches Ramelteon Tablets

  12/15/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Ramelteon Tablets, 8 mg. Upsher-Smith's product is AB-rated to the branded product, ROZEREM ® (ramelteon) tablets.* Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset.

• Upsher-Smith Reimagines Prescriber Education With Launch Of Migraine PeerConnect

  12/7/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that as part of its ongoing effort to reimagine prescriber education during the COVID-19 pandemic, it has launched a new and innovative peer-to-peer product education program entitled Migraine PeerConnect.

• Upsher-Smith Supports The American Headache Society's Virtual 2020 Scottsdale Headache Symposium® As Gold Level Sponsor

  11/16/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the American Headache Society's 2020 Scottsdale Headache Symposium® as a Gold Level Sponsor. Due to the COVID-19 pandemic

• Amina Abubakar Of Charlotte, North Carolina Named 2020 Willard B. Simmons Independent Pharmacist Of The Year

  10/19/2020

  Known as the "Mother Theresa of Healthcare", Abubakar Earns Award for Tireless Service to Community Health and Advancing Pharmacy Education

• Upsher-Smith's Brad Leonard And Amy Dearborn Honored By Cardinal Health For Outstanding Service

  10/16/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that two of its employees have received top honors from Cardinal Health for their outstanding service and performance for the previous year. Brad Leonard ,

• Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop and Market Corticotropin Injection

  8/7/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) and AmbioPharm, Inc. (AmbioPharm) today announced that the companies have entered into a partnership agreement to develop and market Corticotropin Injection in the U.S. The market for adrenocorticotropic hormone or ACTH (brand Acthar ® Gel*) is currently

• Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules

  6/30/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Propafenone Hydrochloride Extended-Release Capsules in 225 mg, 325 mg and 425 mg strengths

• Upsher-Smith Offers Help To People With Migraines During National Migraine And Headache Awareness Month

  6/23/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its continued commitment to people who suffer from migraines during National Migraine & Headache Awareness Month (MHAM). The COVID-19 pandemic has made it

• Upsher-Smith Launches Ethacrynic Acid Tablets, USP

  6/23/2020

   Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Ethacrynic Acid Tablets, USP in 25 mg strength.

• Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories

  4/20/2020

  Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the Company has been successful in its binding arbitration with Upsher-Smith Laboratories LLC ("Upsher-Smith").

• Upsher-Smith Kicks Off 2020 With Three Generic Product Launches

  2/19/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its generic portfolio with the recent launch of three new products: Fluvoxamine Maleate Tablets, Haloperidol Tablets, USP, and Clonidine Hydrochloride Extended-Release Tablets

• Upsher-Smith And The National Alliance Of State Pharmacy Associations (NASPA) Recognize 44 U.S. Pharmacists With Excellence In Innovation Award

  2/18/2020

  Awardees Selected for Their Commitment to Patients and Effort in Advancing the Pharmacy Profession

• Upsher-Smith Launches Clonidine Hydrochloride Extended-Release Tablets

  1/28/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clonidine Hydrochloride Extended-Release Tablets in 0.1 mg strength. Upsher-Smith's product is AB1-rated to the branded product, KAPVAY® (clonidine hydrochloride) extended-release tablets

• Upsher-Smith Launches Fluvoxamine Maleate Tablets

  1/10/2020

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Fluvoxamine Maleate Tablets in 25 mg, 50 mg and 100 mg strengths.

• Upsher-Smith To Attend 2019 Annual Meeting Of The American Epilepsy Society

  12/6/2019

  Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the 2019 Annual Meeting of the American Epilepsy Society (AES) December 6-10, 2019 in Baltimore, MD

• Upsher-Smith Laboratories Adds Zembrace® SymTouch® (sumatriptan) Injection To Its Access Pathways® Platinum Pass® Savings Program

  11/18/2019

  Program Provides Access and Affordability for Patients Seeking Treatment for Acute Migraine

• Steve Moore Of Plattsburgh, New York Honored With 2019 Willard B. Simmons Independent Pharmacist Of The Year Award

  10/29/2019

  Upsher-Smith Laboratories, LLC is pleased to announce Steve Moore, PharmD, who along with his family, owns Condo Pharmacy in Plattsburgh, New York as the winner of the 2019 National Community Pharmacist Association Independent Pharmacist of the Year award.